EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Numerator:
Net income from continuing operations	$ 490	$ 386	$ 1,312	$ 1,202
Net (income) loss attributable to noncontrolling interests	(19)	(7)	(40)	(33)
Net income from continuing operations attributable to GE HealthCare	470	379	1,272	1,169
Deemed preferred stock dividend of redeemable noncontrolling interest	0	0	0	(183)
Net income from continuing operations attributable to GE HealthCare common stockholders	470	379	1,272	986
Income (loss) from discontinued operations, net of taxes	0	(4)	0	(4)
Net income attributable to GE HealthCare common stockholders	$ 470	$ 375	$ 1,272	$ 982
Denominator:
Basic weighted-average shares outstanding	457	455	456	455
Dilutive effect of common stock equivalents (in shares)	2	3	2	3
Diluted weighted-average shares outstanding	459	458	459	458
Basic Earnings Per Share:
Continuing operations (in dollars per share)	$ 1.03	$ 0.83	$ 2.79	$ 2.17
Discontinued operations (in dollars per share)	0	(0.01)	0	(0.01)
Attributable to GE HealthCare common stockholders (in dollars per share)	1.03	0.82	2.79	2.16
Diluted Earnings Per Share:
Continuing operations (in dollars per share)	1.02	0.83	2.77	2.16
Discontinued operations (in dollars per share)	0	(0.01)	0	(0.01)
Attributable to GE HealthCare common stockholders (in dollars per share)	$ 1.02	$ 0.82	$ 2.77	$ 2.15
Antidilutive securities (in shares)	2	4	4	4